close
close

Herbal supplements recalled; may contain drugs not listed on label – WFTV

The US Food and Drug Administration has announced a recall of the herbal dietary supplement capsules Infla-650, which were marketed for pain relief.

The capsules were contaminated with paracetamol, diclofenac and phenylbutazone, all of which are not listed on the dietary supplement label.

If the ingredients are included in a product, it cannot be marketed as a dietary supplement, the FDA said.

The agency also stated that the supplement was not approved as a new drug “whose safety and efficacy have not yet been established and which could therefore be subject to a recall.”

The FDA stated that taking these supplements carries the risk of an intentional overdose of acetaminophen, which could lead to liver damage.

Diclofenac is a nonsteroidal anti-inflammatory drug, or NSAID. Taking NSAIDs may increase the risk of cardiovascular disease and gastrointestinal damage and may interact with other medications.

Phenylbutazone is a discontinued NSAID that can cause bone marrow damage. It is not approved for use in humans.

The recalled Infla-650 herbal supplement capsules were sold with the lot number IN-032 and an expiration date of November 2027. They have a silver stand-up pouch that contains 60 capsules. They were shipped to retailers nationwide and through nutraherbusa.com and nutra650.com from March 4 to June 24.

Anyone in possession of the supplements is advised not to take them and to return them to where they purchased them, the FDA said.